Videos

After briefly introducing themselves, Trinity Bivalacqua, MD, PhD and Mark Tyson, MD, MPH discuss approximately how many newly diagnosed bladder cancer patients have non-muscle invasive bladder cancer, or NMIBC.

"Kidney stone treatment is all about access," says Joseph Song, MD.

"By using our technique, and really preserving that urethral length really well, it seems to help those patients in particular to have better outcomes," David I. Lee, MD, FACS.

“With the support of the pediatric department and the pediatric urologists I work very closely with, we've been very successful in identifying the right patients,” says John Michael DiBianco, MD.

"Compared to the prior years, we found that there was a 150% increase in new vasectomy consults that were completed, and there was a 160% increase in the number of vasectomies that were done," says Catherine S. Nam, MD.

"Understanding that biology of that tumor and/or combining or using multiple radiotracers, either simultaneously or in sequence, may really be exciting to identify where those tumors are located," says Brian T. Helfand, MD, PhD.

“Our goal is to support patients throughout their entire journey with an intelligence chat system that not only evaluates them, but also answers many questions when their treating physician is not available, which is very common,” says Juan Fulla, MD, MSc.

"I think that coping is a key way that we can help intervene here," says Elisabeth M. Sebesta, MD.

Kyrollis Attalla, MD, describes the role of fusion-based biopsies in active surveillance for patients with prostate cancer and how this technology has improved monitoring and treatment strategies.

“Interestingly, the trainees, when you look at residents as a conglomerate, experienced burnout at a higher rate than post-trainee urologists,” says Andrew M. Harris, MD.

A urologic oncologist discusses how MRI- or fusion-guided biopsies have helped overcome the limitations of traditional prostate biopsies.

"There are many opportunities to support our patients with bladder cancer who smoke from their clinic appointments from their intravesical therapy visits to their surveillance cystoscopies," says Marc Bjurlin, DO, MSc, FACOS.

“I think this is really playing a role in the decision for where we're localizing our radiation therapies as well as the addition of ADT plus an androgen receptor pathway inhibitor, ARPI, and the duration of these therapies,” says Brian T. Helfand, MD, PhD.

“Our final goal is to shift from an episodic care to continuous patient follow-up, allowing us to better understand and manage the evolution of patients over the time,” says Juan Fulla, MD, MSc.

"I think the biggest take-home message is just the importance of genetic testing," says Adri Durant, MD.

“And certainly, while most of these studies are ongoing, the initial data looks promising to say that there may be a role for a PSMA next-generation imaging in the decision for the appropriateness for active surveillance,” says Brian T. Helfand, MD, PhD.

Tony Abraham, DO, MPA, outlines the limitations of PSMA-PET imaging and discusses the importance of multidisciplinary care in overcoming challenges surrounding the interpretation and reporting of imaging results.

“Many of us feel privileged to take care of our patients, and that's why we went into the health care profession. However, at some point, that amount of call and how it affects work/life balance becomes difficult,” says Andrew M. Harris, MD.

“For us, this approach has the potential to transform the prevention and management of urolithiasis, making health care more precise and personalized,” says Juan Fulla, MD, MSc.

"In terms of the psychosocial aspect of things, people with toilet insecurity are more likely to experience greater stress and anxiety, report poorer social support, have a poor overall perception of their health, even after controlling for some confounders," says Elisabeth M. Sebesta, MD.

"Having a better understanding of which PGVs are really putting patients at an increased risk vs others, I think would definitely be something that needs more investigation," says Mouneeb Choudry, MD.

A urologic oncologist discusses how MRI- or fusion-guided biopsies have helped overcome the limitations of traditional prostate biopsies.

Kyrollis Attalla, MD, shares his approach to imaging and biopsy in the diagnosis of prostate cancer and discusses the benefit of a good biopsy followed by appropriate imaging at initial diagnosis.

“Perhaps it's worth giving them questionnaires like the PHQ-9 or GAD-7 to monitor their mental health status and encourage or ask if they even have support around them,” says Olivia Paulsen.

"Anytime we do a PCNL...we always get a CT scan. That's pretty standard," says John Michael DiBianco, MD.

"Our next goal is transitioning to really understand the patient experience and how we can support them to quit smoking cigarettes," says Marc Bjurlin, DO, MSc, FACOS.

"Somebody once gave me a saying: the 3 things that make a person happy every day are somewhere to go, someone to love, and something to look forward to. I have all 3 of them," says Steven A. Kaplan, MD.